This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

David L. Page, MD; Roy A. Jensen, MD
Vanderbilt University Medical Center Nashville, Tenn

JAMA. 1996;276(11):871.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We are not surprised at the diverse responses to the article by Dr Ernster and colleagues¹ and our Editorial because we are all in a transition phase in the acceptance of and therapeutic responses to the heterogeneity of breast cancer, particularly DCIS. It was our opinion of the response of the popular press that most felt that too many women were getting mastectomies, while we thought that it was surprising that so many women were not undergoing mastectomy. Perhaps this is just a matter of perspective and bias of optimism vs pessimism. If our comments accepting this change toward conservative treatment of DCIS and looking forward to more certain evidence from multicenter trials constitutes speaking out of both sides of our mouths (as noted by Dr Vikram), then we so confess. It is not uncommon for surgical practice to change gradually over time as witnessed by the transition to . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?